Europe follows North America to be the second-leading market for hemostasis diagnostics. High awareness and demand for superior quality diagnostics is one of the key factors driving the hemostasis diagnostics market in the region.
Albany, NY -- (SBWIRE) -- 11/15/2017 -- In recent times, rise in the prevalence of genetically inherited disorders such as hemophilia, increase in a number of surgeries and trauma patients, surge in the usage of recombinant products are the collective factors driving the global market for hemostasis diagnostics. This is because it easily helps in identifying the hemostatic defects that cause excessive bleeding. Apart from that, technological breakthroughs leading to the development of advanced products for hemostasis diagnostics is also stoking growth of this market. These key findings have been clearly stated in a new study, broadcasted to the wide repository of Market Research Hub (MRH), with the title of "Hemostasis Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025". The research is a combination of primary and secondary research, and deeply analyzes the current and future prospects of the market. The major highlight of the study is that it estimates market size in terms of US$ Mn for each segment within the market for the period from 2015 to 2025, considering the macro and micro environmental factor.
Request Free Sample Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=173421
As per the analysis by the World Health Organization (WHO), an estimated 400, 000 people worldwide suffer from hemophilia, of which 56% remain undiagnosed. Hemophilia, vitamin k deficiency, and disseminated intravascular coagulation are some of the factors responsible for blood clotting disorders that not only requires relevant treatment, but also timely and affordable diagnosis. In this scenario, the ultimate goal of the hemostatic system is to form a clot to prevent further hemorrhage. This will stoke growth of the hemostasis diagnostics market. According to the recent findings, the global hemostasis diagnostics market projected to inflate at a strong CAGR of 8.3% between 2017 and 2025. At this pace, the market is expected to attract a revenue of US$3,979.5 mn by 2025 from US$1,960.0 mn in 2016.
To provide better and accurate results, the report majorly focuses on some of the prime regions including the Middle East and Africa (MEA), Europe, Asia Pacific, Japan, North America, and Latin America. In the first part, the report talks about the precise market overview of hemostasis diagnostics, including a market snapshot which provides information on various segments and sub-segments. The research then shifts focus towards the major dynamics, including drivers, trends, opportunities as well as restraints in the global hemostasis diagnostic market. In the present time, current technologies for hemostasis diagnostics include automation of blood coagulation analyzers, flow cytometers, microarrays, and PCR that are less labor intensive, rapid, and easy-to-use. The incorporation of these technologies during surgeries is anticipated to provide several opportunities for companies operating in the market.
Browse Full Report with TOC- https://www.marketresearchhub.com/report/hemostasis-diagnostics-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html
Moreover, the report briefly explains the market segmentation of hemostatic diagnostics based on few parameters such as product type, test type and end-user. Major product types in the market are Laboratory Systems, Manual Systems, Automated Systems, Point-of-Care Testing Systems, Semi-automated Systems and Consumables. On the basis of test type, the study covers Prothrombin Test Time (PT), Activated Clotting Time, Fibrinogen degradation products (FDP), Activated partial thromboplastin time (APTT), D Dimer and Platelet Aggregation Test. The research also finds that among various end-users Hospital/clinics is likely to expand at a significant growth rate over the forecast period of 2017-2022. In terms of geography, North America held the leading market share in 2016, but as per the current scenario, Asia Pacific is anticipated to surpass all other regions in terms of growth rate from 2017 to 2025.
At last, the report deals with the competitive landscape which highlights the key players that are operating in the hemostasis diagnostics market. Key companies profiled in the report include Abbott Laboratories, Siemens Healthineers, Alere, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Instrumentation Laboratory, Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation (Beckman Coulter), and Grifols, S.A.
Enquire about this Report- https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=173421
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
90 State Street,
Albany, NY 12207,
Toll Free : 800-998-4852 (US-Canada)
Email : email@example.com
Website : https://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/